While natural Δ 9-tetrahidrocannabinol (Δ 9 THC), cannabidiol (CBD), and their therapeutic
potential have been extensively researched, some cannabinoids have been less extensively …

During these last years, the CB 2 cannabinoid receptor has emerged as a potential anti-
inflammatory target in diseases such as multiple sclerosis, amyotrophic lateral sclerosis …

The mechanism of action of cannabidiol (CBD), the main non-psychotropic component of
Cannabis sativa L., is not completely understood. First assumed that the compound was …

Background Recent approved medicines whose active principles are Δ 9
Tetrahidrocannabinol (Δ 9-THC) and/or cannabidiol (CBD) open novel perspectives for …

Cannabigerol (CBG) is one of the major phytocannabinoids present in Cannabis sativa L.
that is attracting pharmacological interest because it is non-psychotropic and is abundant in …

A series of highly luminescent europium (III) complexes which exhibit photoluminescence
from the Eu (III) center following energy transfer from the UV absorbing organic sensitizer …

Pharmacological modulation of cannabinoid type 2 receptor (CB2R) holds promise for the
treatment of numerous conditions, including inflammatory diseases, autoimmune disorders …

We have here assessed, using Δ 9-tetrahydrocannabinol (Δ 9-THC) for comparison, the
effect of Δ 9-tetrahydrocannabinolic acid (Δ 9-THCA) and of Δ 9-tetrahydrocannabivarin (Δ9 …

A growing number of studies suggest therapeutic applications of cannabidiol (CBD), a
recently US Food and Drug Administration (FDA)–approved medication for epilepsy, in …

The gut microbiota plays a fundamental role on the education and function of the host
immune system. Immunological dysregulation is the cause of numerous human disorders …